| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Influenza, Human | 9 | 2023 | 924 | 1.130 |
Why?
|
| Respiratory Insufficiency | 5 | 2023 | 330 | 0.970 |
Why?
|
| Extracorporeal Membrane Oxygenation | 7 | 2023 | 585 | 0.810 |
Why?
|
| Apnea | 1 | 2020 | 30 | 0.750 |
Why?
|
| Systemic Inflammatory Response Syndrome | 7 | 2023 | 181 | 0.720 |
Why?
|
| Brain Death | 1 | 2020 | 53 | 0.720 |
Why?
|
| Advance Care Planning | 1 | 2021 | 86 | 0.720 |
Why?
|
| GABA Modulators | 1 | 2018 | 15 | 0.670 |
Why?
|
| Pentobarbital | 1 | 2018 | 29 | 0.660 |
Why?
|
| Child | 47 | 2023 | 29120 | 0.620 |
Why?
|
| Status Epilepticus | 1 | 2018 | 145 | 0.580 |
Why?
|
| Terminal Care | 1 | 2021 | 446 | 0.550 |
Why?
|
| Drug Resistant Epilepsy | 1 | 2018 | 181 | 0.540 |
Why?
|
| Coinfection | 2 | 2019 | 189 | 0.530 |
Why?
|
| Water-Electrolyte Imbalance | 2 | 2017 | 92 | 0.520 |
Why?
|
| Intensive Care Units, Pediatric | 8 | 2021 | 441 | 0.480 |
Why?
|
| Acute Kidney Injury | 6 | 2021 | 747 | 0.470 |
Why?
|
| Respiratory Tract Infections | 3 | 2023 | 437 | 0.470 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 2 | 2012 | 242 | 0.460 |
Why?
|
| Nervous System Diseases | 3 | 2023 | 499 | 0.450 |
Why?
|
| Child, Hospitalized | 3 | 2022 | 62 | 0.420 |
Why?
|
| Pediatrics | 1 | 2021 | 1136 | 0.410 |
Why?
|
| Staphylococcal Infections | 2 | 2019 | 673 | 0.400 |
Why?
|
| Child, Preschool | 24 | 2022 | 16244 | 0.400 |
Why?
|
| Critical Illness | 12 | 2022 | 714 | 0.400 |
Why?
|
| Blood Coagulation Disorders | 1 | 2012 | 120 | 0.390 |
Why?
|
| Fluid Therapy | 1 | 2012 | 181 | 0.380 |
Why?
|
| Myelitis | 2 | 2020 | 26 | 0.360 |
Why?
|
| Infant | 21 | 2023 | 13291 | 0.350 |
Why?
|
| Neuromuscular Diseases | 2 | 2020 | 63 | 0.350 |
Why?
|
| Adolescent | 29 | 2023 | 31246 | 0.330 |
Why?
|
| Staphylococcus aureus | 1 | 2012 | 549 | 0.320 |
Why?
|
| Oxygen | 1 | 2012 | 754 | 0.310 |
Why?
|
| Severity of Illness Index | 5 | 2019 | 4346 | 0.280 |
Why?
|
| Hospital Mortality | 4 | 2022 | 1308 | 0.280 |
Why?
|
| Aftercare | 3 | 2022 | 261 | 0.270 |
Why?
|
| von Willebrand Diseases | 2 | 2019 | 61 | 0.260 |
Why?
|
| Critical Care | 4 | 2021 | 771 | 0.260 |
Why?
|
| Hospitalization | 9 | 2023 | 2117 | 0.250 |
Why?
|
| DEAD Box Protein 58 | 2 | 2022 | 14 | 0.240 |
Why?
|
| Humans | 53 | 2023 | 262170 | 0.230 |
Why?
|
| Hemorrhage | 3 | 2019 | 712 | 0.230 |
Why?
|
| Central Nervous System Viral Diseases | 2 | 2020 | 13 | 0.230 |
Why?
|
| Transcription Factor AP-1 | 1 | 2004 | 244 | 0.220 |
Why?
|
| Respiration, Artificial | 5 | 2023 | 578 | 0.220 |
Why?
|
| Airway Obstruction | 1 | 2006 | 261 | 0.220 |
Why?
|
| Guillain-Barre Syndrome | 1 | 2023 | 35 | 0.220 |
Why?
|
| Receptors, Immunologic | 2 | 2022 | 309 | 0.210 |
Why?
|
| Tachycardia, Supraventricular | 1 | 2022 | 84 | 0.200 |
Why?
|
| Escherichia coli Infections | 1 | 2004 | 250 | 0.200 |
Why?
|
| Interferon Type I | 1 | 2022 | 250 | 0.200 |
Why?
|
| Hypoxia | 1 | 2004 | 445 | 0.190 |
Why?
|
| Cardiotonic Agents | 2 | 2021 | 155 | 0.190 |
Why?
|
| Male | 31 | 2023 | 123260 | 0.190 |
Why?
|
| Creatinine | 2 | 2019 | 541 | 0.180 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2021 | 181 | 0.180 |
Why?
|
| Patient Discharge | 5 | 2022 | 667 | 0.180 |
Why?
|
| Retrospective Studies | 16 | 2023 | 38002 | 0.180 |
Why?
|
| Communicable Diseases | 1 | 2022 | 197 | 0.180 |
Why?
|
| NF-kappa B | 2 | 2022 | 1551 | 0.180 |
Why?
|
| Neurologic Examination | 1 | 2020 | 245 | 0.180 |
Why?
|
| Renal Replacement Therapy | 1 | 2021 | 136 | 0.180 |
Why?
|
| Respiratory Tract Diseases | 1 | 2020 | 111 | 0.180 |
Why?
|
| Mannose-Binding Lectin | 1 | 2019 | 8 | 0.170 |
Why?
|
| Health Information Systems | 1 | 2020 | 34 | 0.170 |
Why?
|
| Enterovirus Infections | 1 | 2020 | 47 | 0.170 |
Why?
|
| Bacterial Infections | 1 | 2023 | 479 | 0.170 |
Why?
|
| Documentation | 1 | 2021 | 207 | 0.170 |
Why?
|
| Respiratory Syncytial Virus Infections | 1 | 2023 | 427 | 0.170 |
Why?
|
| Female | 30 | 2023 | 142222 | 0.170 |
Why?
|
| Kidney Function Tests | 1 | 2019 | 194 | 0.170 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2020 | 206 | 0.160 |
Why?
|
| Patient-Centered Care | 1 | 2021 | 298 | 0.160 |
Why?
|
| Vasoconstrictor Agents | 1 | 2018 | 151 | 0.160 |
Why?
|
| Influenza A virus | 1 | 2019 | 270 | 0.150 |
Why?
|
| Heart Arrest | 1 | 2022 | 360 | 0.150 |
Why?
|
| Sepsis | 2 | 2022 | 655 | 0.150 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2021 | 430 | 0.150 |
Why?
|
| Glucocorticoids | 1 | 2021 | 637 | 0.150 |
Why?
|
| Prospective Studies | 11 | 2023 | 12914 | 0.150 |
Why?
|
| Informed Consent | 1 | 2020 | 419 | 0.150 |
Why?
|
| Resuscitation Orders | 1 | 2016 | 68 | 0.140 |
Why?
|
| Infant, Extremely Premature | 1 | 2016 | 75 | 0.140 |
Why?
|
| Orthomyxoviridae | 1 | 2016 | 94 | 0.140 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2019 | 308 | 0.140 |
Why?
|
| Survivors | 1 | 2021 | 1035 | 0.130 |
Why?
|
| Treatment Outcome | 10 | 2022 | 32986 | 0.130 |
Why?
|
| Stroke | 1 | 2023 | 1155 | 0.120 |
Why?
|
| Quality Improvement | 1 | 2021 | 855 | 0.120 |
Why?
|
| Intensive Care Units | 3 | 2023 | 717 | 0.120 |
Why?
|
| Logistic Models | 3 | 2021 | 3450 | 0.120 |
Why?
|
| Mutation, Missense | 1 | 2019 | 1154 | 0.120 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2016 | 333 | 0.120 |
Why?
|
| Parents | 1 | 2020 | 1004 | 0.110 |
Why?
|
| Electronic Health Records | 1 | 2021 | 929 | 0.110 |
Why?
|
| Length of Stay | 3 | 2018 | 1929 | 0.110 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 2 | 2022 | 6558 | 0.110 |
Why?
|
| Clinical Decision-Making | 1 | 2016 | 527 | 0.110 |
Why?
|
| Pandemics | 3 | 2023 | 1566 | 0.110 |
Why?
|
| Registries | 1 | 2020 | 2187 | 0.110 |
Why?
|
| Follow-Up Studies | 4 | 2020 | 14902 | 0.100 |
Why?
|
| Virus Diseases | 1 | 2016 | 399 | 0.100 |
Why?
|
| Infant, Newborn | 7 | 2022 | 8219 | 0.100 |
Why?
|
| Acute Disease | 3 | 2020 | 2424 | 0.100 |
Why?
|
| Medical Audit | 1 | 2012 | 189 | 0.100 |
Why?
|
| Decision Support Techniques | 1 | 2017 | 623 | 0.100 |
Why?
|
| Factor V | 1 | 2011 | 20 | 0.100 |
Why?
|
| United States | 7 | 2023 | 15559 | 0.100 |
Why?
|
| Cross-Sectional Studies | 4 | 2023 | 4329 | 0.100 |
Why?
|
| Oximetry | 1 | 2012 | 172 | 0.100 |
Why?
|
| Emergency Service, Hospital | 1 | 2018 | 1155 | 0.090 |
Why?
|
| Quality of Life | 2 | 2021 | 4578 | 0.090 |
Why?
|
| Proportional Hazards Models | 2 | 2022 | 5008 | 0.080 |
Why?
|
| Linear Models | 1 | 2012 | 1090 | 0.080 |
Why?
|
| Multivariate Analysis | 2 | 2017 | 4321 | 0.080 |
Why?
|
| Decision Making | 1 | 2016 | 1294 | 0.080 |
Why?
|
| Biomarkers | 5 | 2022 | 5051 | 0.080 |
Why?
|
| Signal Transduction | 2 | 2020 | 11970 | 0.080 |
Why?
|
| Interleukin-18 | 1 | 2007 | 101 | 0.070 |
Why?
|
| Lipocalins | 1 | 2007 | 54 | 0.070 |
Why?
|
| Acute-Phase Proteins | 1 | 2007 | 77 | 0.070 |
Why?
|
| Nurses | 1 | 2007 | 82 | 0.070 |
Why?
|
| Peritonsillar Abscess | 1 | 2006 | 4 | 0.070 |
Why?
|
| Retropharyngeal Abscess | 1 | 2006 | 11 | 0.070 |
Why?
|
| Epiglottitis | 1 | 2006 | 16 | 0.070 |
Why?
|
| Tracheitis | 1 | 2006 | 21 | 0.070 |
Why?
|
| Croup | 1 | 2006 | 15 | 0.070 |
Why?
|
| Workload | 1 | 2007 | 199 | 0.070 |
Why?
|
| Laryngeal Diseases | 1 | 2006 | 49 | 0.070 |
Why?
|
| Risk Factors | 5 | 2023 | 17606 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2019 | 5540 | 0.070 |
Why?
|
| Hospitals, Pediatric | 2 | 2022 | 773 | 0.070 |
Why?
|
| Odds Ratio | 2 | 2022 | 2326 | 0.060 |
Why?
|
| Medical Errors | 1 | 2007 | 220 | 0.060 |
Why?
|
| Thrombosis | 1 | 2011 | 782 | 0.060 |
Why?
|
| Glutathione Disulfide | 1 | 2004 | 20 | 0.060 |
Why?
|
| Xanthine Oxidase | 1 | 2004 | 21 | 0.060 |
Why?
|
| NF-KappaB Inhibitor alpha | 1 | 2004 | 136 | 0.060 |
Why?
|
| Young Adult | 5 | 2022 | 21473 | 0.060 |
Why?
|
| Brain Infarction | 1 | 2004 | 31 | 0.060 |
Why?
|
| Marijuana Smoking | 1 | 2004 | 40 | 0.060 |
Why?
|
| Steroids | 1 | 2006 | 356 | 0.060 |
Why?
|
| I-kappa B Proteins | 1 | 2004 | 170 | 0.060 |
Why?
|
| Crowding | 1 | 2023 | 8 | 0.060 |
Why?
|
| NF-kappa B p52 Subunit | 1 | 2022 | 26 | 0.060 |
Why?
|
| Intubation, Intratracheal | 1 | 2007 | 445 | 0.050 |
Why?
|
| Respiratory Syncytial Viruses | 1 | 2023 | 171 | 0.050 |
Why?
|
| Family Characteristics | 1 | 2023 | 102 | 0.050 |
Why?
|
| Oxidation-Reduction | 1 | 2004 | 719 | 0.050 |
Why?
|
| Glutathione | 1 | 2004 | 366 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2023 | 6105 | 0.050 |
Why?
|
| Cytoplasm | 1 | 2004 | 649 | 0.050 |
Why?
|
| Multiple Organ Failure | 1 | 2023 | 178 | 0.050 |
Why?
|
| Glasgow Coma Scale | 1 | 2022 | 215 | 0.050 |
Why?
|
| Immunoassay | 1 | 2022 | 215 | 0.050 |
Why?
|
| Neutralization Tests | 1 | 2022 | 298 | 0.050 |
Why?
|
| Seasons | 1 | 2023 | 340 | 0.050 |
Why?
|
| Public Health Surveillance | 1 | 2021 | 63 | 0.050 |
Why?
|
| Interferons | 1 | 2022 | 290 | 0.050 |
Why?
|
| Haploinsufficiency | 1 | 2022 | 293 | 0.050 |
Why?
|
| Laboratories, Hospital | 1 | 2021 | 29 | 0.050 |
Why?
|
| Patient Acuity | 1 | 2021 | 74 | 0.050 |
Why?
|
| Viral Envelope Proteins | 1 | 2022 | 207 | 0.050 |
Why?
|
| Antigens, Viral | 1 | 2022 | 467 | 0.050 |
Why?
|
| Age Factors | 2 | 2021 | 5385 | 0.050 |
Why?
|
| Cohort Studies | 3 | 2021 | 9292 | 0.050 |
Why?
|
| Cerebellum | 1 | 2004 | 448 | 0.050 |
Why?
|
| Shock | 1 | 2021 | 89 | 0.050 |
Why?
|
| Coagulants | 1 | 2019 | 8 | 0.040 |
Why?
|
| Obesity | 2 | 2023 | 2893 | 0.040 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2022 | 224 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2012 | 6892 | 0.040 |
Why?
|
| Morbidity | 1 | 2021 | 401 | 0.040 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2022 | 234 | 0.040 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2022 | 705 | 0.040 |
Why?
|
| Immunomodulation | 1 | 2021 | 243 | 0.040 |
Why?
|
| Factor VIII | 1 | 2019 | 76 | 0.040 |
Why?
|
| Patient Admission | 1 | 2021 | 222 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2004 | 2073 | 0.040 |
Why?
|
| Incidence | 2 | 2021 | 5709 | 0.040 |
Why?
|
| Reactive Oxygen Species | 1 | 2004 | 990 | 0.040 |
Why?
|
| Delphi Technique | 1 | 2019 | 214 | 0.040 |
Why?
|
| Autoantibodies | 1 | 2022 | 580 | 0.040 |
Why?
|
| Medical Staff, Hospital | 1 | 2019 | 120 | 0.040 |
Why?
|
| Combined Modality Therapy | 2 | 2021 | 8883 | 0.040 |
Why?
|
| Texas | 2 | 2020 | 6307 | 0.040 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2022 | 478 | 0.040 |
Why?
|
| Adult | 6 | 2023 | 78082 | 0.040 |
Why?
|
| Cell Nucleus | 1 | 2004 | 1616 | 0.040 |
Why?
|
| Stroke Volume | 1 | 2021 | 574 | 0.040 |
Why?
|
| Early Diagnosis | 1 | 2019 | 301 | 0.040 |
Why?
|
| Propensity Score | 1 | 2021 | 755 | 0.040 |
Why?
|
| Oxidative Stress | 1 | 2004 | 1131 | 0.040 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2007 | 2485 | 0.040 |
Why?
|
| Regression Analysis | 1 | 2021 | 1550 | 0.040 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2022 | 425 | 0.040 |
Why?
|
| Reference Values | 1 | 2019 | 1098 | 0.040 |
Why?
|
| Inpatients | 1 | 2023 | 687 | 0.040 |
Why?
|
| Membrane Glycoproteins | 1 | 2022 | 1070 | 0.040 |
Why?
|
| Amino Acid Substitution | 1 | 2019 | 642 | 0.040 |
Why?
|
| Neonatologists | 1 | 2016 | 16 | 0.040 |
Why?
|
| Activities of Daily Living | 1 | 2020 | 560 | 0.040 |
Why?
|
| Time Factors | 2 | 2021 | 12968 | 0.040 |
Why?
|
| Multiplex Polymerase Chain Reaction | 1 | 2016 | 50 | 0.030 |
Why?
|
| Syndrome | 1 | 2019 | 1352 | 0.030 |
Why?
|
| Predictive Value of Tests | 2 | 2019 | 4901 | 0.030 |
Why?
|
| Fatal Outcome | 2 | 2011 | 826 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2004 | 3127 | 0.030 |
Why?
|
| Community-Acquired Infections | 1 | 2018 | 285 | 0.030 |
Why?
|
| Nasopharynx | 1 | 2016 | 118 | 0.030 |
Why?
|
| Interferon-alpha | 1 | 2020 | 889 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2021 | 2323 | 0.030 |
Why?
|
| Antibodies, Viral | 1 | 2022 | 1318 | 0.030 |
Why?
|
| Risk | 1 | 2020 | 1972 | 0.030 |
Why?
|
| ROC Curve | 1 | 2018 | 1180 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2018 | 1329 | 0.030 |
Why?
|
| Rats | 1 | 2004 | 6108 | 0.030 |
Why?
|
| Cytokines | 1 | 2004 | 2812 | 0.030 |
Why?
|
| Transcriptome | 1 | 2023 | 1859 | 0.030 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2016 | 272 | 0.030 |
Why?
|
| Physician's Role | 1 | 2016 | 241 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2020 | 1539 | 0.030 |
Why?
|
| Liver | 1 | 2004 | 2904 | 0.030 |
Why?
|
| Prevalence | 1 | 2022 | 3271 | 0.030 |
Why?
|
| Specimen Handling | 1 | 2016 | 299 | 0.030 |
Why?
|
| Sex Factors | 1 | 2019 | 2156 | 0.030 |
Why?
|
| Neoplasms | 1 | 2020 | 15201 | 0.030 |
Why?
|
| Cost of Illness | 1 | 2017 | 502 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2006 | 2995 | 0.030 |
Why?
|
| Transplantation Conditioning | 1 | 2022 | 2237 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2020 | 2234 | 0.030 |
Why?
|
| Antiviral Agents | 1 | 2020 | 1231 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2016 | 1222 | 0.030 |
Why?
|
| Disease Progression | 1 | 2023 | 6695 | 0.030 |
Why?
|
| Phenotype | 1 | 2023 | 6265 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2021 | 4755 | 0.030 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2011 | 68 | 0.020 |
Why?
|
| Prognosis | 2 | 2020 | 21745 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2022 | 4555 | 0.020 |
Why?
|
| Hemoglobins | 1 | 2011 | 477 | 0.020 |
Why?
|
| Pregnancy | 1 | 2022 | 7549 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2020 | 5713 | 0.020 |
Why?
|
| Lipocalin-2 | 1 | 2007 | 65 | 0.020 |
Why?
|
| Survival Rate | 1 | 2020 | 12236 | 0.020 |
Why?
|
| Nursing Staff, Hospital | 1 | 2007 | 69 | 0.020 |
Why?
|
| Blood Platelets | 1 | 2011 | 730 | 0.020 |
Why?
|
| Headache | 1 | 2004 | 162 | 0.010 |
Why?
|
| Animals | 1 | 2004 | 59504 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2007 | 4977 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2004 | 7572 | 0.000 |
Why?
|